Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
60
TIGO Quote, Financials, Valuation and Earnings
Last price:
$24.50
Seasonality move
:
1.67%
Day range:
$24.38 - $24.55
52-week range:
$15.55 - $28.75
Dividend yield:
0%
P/E ratio:
26.87x
P/S ratio:
0.72x
P/B ratio:
1.10x
Volume:
156.4K
Avg. volume:
141.5K
1-year change:
36.67%
Market cap:
$4.2B
Revenue:
$5.7B
EPS (TTM):
$0.91
Analysts' Opinion
-
Consensus RatingMillicom International Cellular SA has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Millicom International Cellular SA has an estimated upside of 36.84% from its current price of $24.45.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $24.45.
Fair Value
-
According to the consensus of 0 analysts, Millicom International Cellular SA has 36.84% upside to fair value with a price target of -- per share.
TIGO vs. S&P 500
-
Over the past 5 trading days, Millicom International Cellular SA has overperformed the S&P 500 by 2.24% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Millicom International Cellular SA does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Millicom International Cellular SA has grown year-over-year revenues for 5 quarters straight. In the most recent quarter Millicom International Cellular SA reported revenues of $1.4B.
Earnings Growth
-
Millicom International Cellular SA has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Millicom International Cellular SA reported earnings per share of $0.30.
Enterprise value:
9.5B
EV / Invested capital:
0.96x
Price / LTM sales:
0.72x
EV / EBIT:
8.73x
EV / Revenue:
1.62x
PEG ratio (5yr expected):
0.09x
EV / Free cash flow:
15.10x
Price / Operating cash flow:
6.72x
Enterprise value / EBITDA:
4.00x
Gross Profit (TTM):
$4.4B
Return On Assets:
1.1%
Net Income Margin (TTM):
2.7%
Return On Equity:
4.42%
Return On Invested Capital:
1.57%
Operating Margin:
19.99%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $5.5B | $5.6B | $5.9B | $1.4B | $1.4B | |
| Gross Profit | $4B | $4.1B | $4.4B | $1.1B | $1.1B | |
| Operating Income | $828M | $795M | $1.1B | $199M | $286M | |
| EBITDA | $2.8B | $2.1B | $2.4B | $524M | $564M | |
| Diluted EPS | $6.16 | $0.22 | $0.91 | -- | $0.30 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.5B | $1.9B | $2B | $1.9B | $2.8B | |
| Total Assets | $12.3B | $11.4B | $14.2B | $14.5B | $14.1B | |
| Current Liabilities | $2.2B | $2.3B | $1.9B | $2.2B | $2.9B | |
| Total Liabilities | $10.1B | $9.3B | $10.6B | $10.9B | $10.3B | |
| Total Equity | $2.3B | $2.1B | $3.6B | $3.6B | $3.7B | |
| Total Debt | $5.9B | $5.3B | $6.9B | $6.7B | $6.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.3B | $1.2B | $1.5B | $347M | $433M | |
| Cash From Investing | -$3.2B | -$966M | -$773M | -$204M | -$105M | |
| Cash From Financing | $2.1B | -$405M | -$727M | -$81M | -$316M | |
| Free Cash Flow | $183M | $191M | $627M | $128M | $284M | |
TIGO
Sector
Market Cap
$4.2B
$112.8M
Price % of 52-Week High
85.04%
65.5%
Dividend Yield
0%
0%
Shareholder Yield
3.93%
3.52%
1-Year Price Total Return
36.67%
-15.05%
Beta (5-Year)
1.174
0.704
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$24.59
200-day SMA
Buy
Level
$24.36
Bollinger Bands (100)
Sell
Level
25.39 - 27.37
Chaikin Money Flow
Buy
Level
1.1M
20-day SMA
Sell
Level
$25.26
Relative Strength Index (RSI14)
Sell
Level
38.62
ADX Line
Neutral
Level
Williams %R
Buy
Level
-91.1425
50-day SMA
Sell
Level
$26.32
MACD (12, 26)
Sell
Level
-0.53
25-day Aroon Oscillator
Sell
Level
-64
On Balance Volume
Sell
Level
-1.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.9589)
Sell
CA Score
(Annual)
Level (-1.2242)
Buy
Beneish M-Score
(Annual)
Level (-2.7954)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.5813)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (5)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Millicom offers wireless and fixed-line telecom services primarily in smaller, less developed countries in Latin America. Countries served include Bolivia (100% owned), Nicaragua (100%), Panama (100%), El Salvador (100%), Guatemala (100%), Paraguay (100%), Colombia (50%), and Honduras (67% but not controlled or consolidated in the firm's financial statements). The firm’s wireless networks cover about 120 million people, serving 41 million customers. Its fixed-line networks reach 14 million homes, serving about 4 million broadband customers. Increasingly, Millicom offers converged packages that include broadband with wireless services. The firm has agreed to sell the majority of its wireless towers to SBA Communications for $975 million.
Stock Forecast FAQ
In the current month, TIGO has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The TIGO average analyst price target in the past 3 months is --.
-
Where Will Millicom International Cellular SA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Millicom International Cellular SA share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Millicom International Cellular SA?
Analysts are divided on their view about Millicom International Cellular SA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Millicom International Cellular SA is a Sell and believe this share price will drop from its current level to --.
-
What Is Millicom International Cellular SA's Price Target?
The price target for Millicom International Cellular SA over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is TIGO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Millicom International Cellular SA is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of TIGO?
You can purchase shares of Millicom International Cellular SA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Millicom International Cellular SA shares.
-
What Is The Millicom International Cellular SA Share Price Today?
Millicom International Cellular SA was last trading at $24.50 per share. This represents the most recent stock quote for Millicom International Cellular SA. Yesterday, Millicom International Cellular SA closed at $24.45 per share.
-
How To Buy Millicom International Cellular SA Stock Online?
In order to purchase Millicom International Cellular SA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
